CLEMENTON, N.J.--(BUSINESS WIRE)--CRI Worldwide, Inc., a leading provider of clinical research services to the global pharmaceutical industry, announced that it has partnered with private equity investors Ampersand Ventures and SV Life Sciences in conjunction with the company’s expansion strategy. In addition, CRI announced that Earle Martin has joined the CRI Worldwide Board of Directors as Executive Chairman.
